Dec 21 (Reuters) - Cyxone AB CYXO.ST :
* CYXONE EXECUTES A RIGHTS ISSUE OF SEK 66.9 MILLION SECURED
TO 91
% AHEAD OF THE PHASE 2B STUDY IN RA
* PROCEEDS FROM RIGHTS ISSUE WILL ENABLE US TO IMPLEMENT
NEXT
IMPORTANT STEPS IN DEVELOPMENT OF CYXONE'S NEW TREATMENT FOR
RHEUMATOID ARTHRITIS (RA)
* SUBSCRIPTION PRICE IS SEK 1.75 PER SHARE
* SUBSCRIPTION PERIOD RUNS DURING 3 JANUARY - 21 JANUARY
2022
* CYXONE, PROVIDED THAT RIGHTS ISSUE IS FULLY SUBSCRIBED,
WILL
RECEIVE APPROXIMATELY SEK 66.9 MILLION BEFORE ISSUE COSTS
* THROUGH RIGHTS ISSUE, NUMBER OF SHARES IN CYXONE WILL
INCREASE
BY A MAXIMUM OF 38,206,233 SHARES
Source text for Eikon: ID:nWkr6fjx7f
Further company coverage: CYXO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))